Cm. Pastor et Dm. Payen, EFFECT OF MODIFYING NITRIC-OXIDE PATHWAY ON LIVER CIRCULATION IN A RABBIT ENDOTOXIN-SHOCK MODEL, Shock, 2(3), 1994, pp. 196-202
The role of nitric oxide (NO) inhibition on liver circulation during s
epsis is unknown. To answer this question, we studied the effects of L
-arginine (the substrate for the NO synthase), linsidomine (a direct N
O donor), and N-omega-nitro-L-arginine (an NO inhibitor) on the liver
circulation in anesthetized rabbits previously injected with endotoxin
(Escherichia coli, Salmonella enteridis, and Salmonella minnesota, 40
0 mu g each). After endotoxin administration, and without fluid resusc
itation, rabbits showed a hypodynamic shock with decrease in mean arte
rial pressure (MAP) and aortic blood flow velocity. Portal vein blood
flow velocity decreased, whereas hepatic artery blood flow velocity in
creased. Saline or treatments were injected, 75 min after endotoxin ad
ministration. In saline-treated rabbits, MAP, aortic and portal vein b
lood flow velocities remained steady but hepatic artery blood flow vel
ocity decreased. Only N-omega-nitro-L-arginine (7.5 mg/kg, intravenous
ly) significantly increased MAP compared to saline treatment. However,
aortic, portal vein, and hepatic artery blood flow velocities were lo
wer in rabbits treated with N-omega-nitro-L-arginine than in saline-tr
eated rabbits. L-Arginine (600 mg/kg, intravenously) increased aortic
blood flow and portal vein blood flow velocity with no change on hepat
ic artery blood flow velocity. In contrast, linsidomine (1 mg) increas
ed both hepatic flows. These results show that NO inhibition after end
otoxin injection reduces systemic and liver flows, while NO release fr
om linsidomine improves them. These findings question the usefulness o
f NO inhibition during septic shock, particularly as hepatic failure f
requently occurs in the evolution of the disease.